PATENT CLAIM ANALYSIS

Application Number: 16001679
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "255040"]

Abstract:
The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.

Claim (Index 2):
The method of  claim 1 , wherein the signs and symptoms are ocular itching, ocular redness and lid swelling and associated nasal symptoms.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.76316
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15456249', '13899321', '12888117', '14982258', '12724128']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8888005488820413
- 35 USC 102 Novelty (BERT): 0.7019148985004113
- Combined Prediction Score: 0.8701119838438782
- Mean Citation Score: 730.5944360000003
- Max Citation Score: 761.8855599999997
- Similarity Product: 725.3318722413062

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test